Search
Monday 29 June 2015
  • :
  • :

Pre-Market Stocks Roundup: Oi SA (NYSE:OIBR), Pall (NYSE:PLL), Orexigen Therapeutics, (NASDAQ:OREX), Scorpio Bulkers (NYSE:SALT)

On Thursday, Oi SA (ADR) (NYSE:OIBR)’s shares inclined 0.49% to $2.05.

Oi SA (ADR) (OIBR) following art. 157, section 4, of Law No. 6,404/76 and CVM Instruction No. 358/02, informs its shareholders and the market in general that, after satisfying all of the contractual conditions precedent, the sale by Oi of all shares issued by PT Portugal SGPS, S.A. (“PT Portugal”) to Altice Portugal, S.A. (“Altice Portugal”), primarily encompassing the operations conducted by PT Portugal in Portugal and Hungary, as revealed in the Company’s Material Facts published on December 8, 2014, December 9, 2014, January 22, 2015 and April 22, 2015, became effective on this date.

Altice Portugal disbursed the total amount of 5.789 billion Euros for the acquisition of PT Portugal, of which 4.920 billion Euros were paid in cash to Oi and 869 million Euros were allocated to right away repay outstanding indebtedness of PT Portugal in Euros. The final purchase price is subject to post-closing adjustments to be calculated within the next months as a result of changes in the cash, indebtedness and working capital positions on the closing date.

Oi S.A. provides integrated telecommunication services for residential customers and governmental agencies, in addition to small, medium, and large companies in Brazil. It offers fixed-line voice services, such as installation, monthly subscription, metered services, collect calls, and supplemental local services; domestic and international long-distance services; broadband Internet access services; subscription television services; and bundled services, in addition to owns and operates public telephones.

Pall Corporation (NYSE:PLL)’s shares dropped -0.03% to $124.30.

Pall Corporation (PLL) water filtration system is providing clean drinking water to residents of Grande-Saline, a remote village in northwest Haiti. The system was donated by Pall Corporation as part of SUNY Broome’s Health for Haiti program and began providing water to villagers in early March.

The installed system is a smaller version of the robust Pall Aria membrane systems used in municipal water treatment plants around the world. It draws up to 22 gallons of river water per minute, filtering out harmful bacteria and pathogens, counting cholera and Giardia.

Haiti is the Western Hemisphere’s poorest nation. SUNY Broome’s Health for Haiti program is a comprehensive, multi-faceted undertaking involving multiple partners which comprises corporations, local companies, and area residents willing to donate their time, skill, and funds.

Pall Corporation manufactures and markets filtration, separation, and purification products; and integrated systems solutions worldwide. Its Life Sciences segment provides technologies that facilitate the process of drug discovery, development, regulatory validation, and production, which are used in the research laboratories, pharmaceutical, biotechnology, and food and beverage industries, in addition to in hospitals.

At the end of Thursday’s trade, Orexigen Therapeutics, Inc. (NASDAQ:OREX)‘s shares surged 0.86% to $4.68.

Orexigen Therapeutics, Inc. (OREX) declared that administration will take part in a fireside chat talk aboution at the JMP Securities Life Sciences Conference in New York. The talk about is planned for Tuesday, June 23rd at 4 p.m. Eastern Time.

Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical products in the United States. The company offers Contrave for the treatment of obesity. It has a partnership agreement with Takeda Pharmaceutical Company Limited to develop and commercialize Contrave in Canada and Mexico. Orexigen Therapeutics, Inc. was founded in 2002 and is headquartered in La Jolla, California.

Scorpio Bulkers Inc (NYSE:SALT), ended its Thursday’s trading session with -3.45% loss, and closed at $1.68.

Scorpio Bulkers Inc (SALT) declared that its Board of Directors has unanimously adopted a stockholder rights plan (the “Rights Plan”) and declared a dividend distribution of one preferred share purchase right on each outstanding share of the Company’s common stock. The Rights Plan has a term of one year.

The Board of Directors adopted the Rights Plan in order to assist promote the fair and equal treatment of all stockholders and enable them to realize the long-term value of their investment in the Company. The Rights Plan is also designed to reduce the likelihood that any person or group would gain control of the Company through open market accumulation or other coercive tactics without paying an appropriate control premium. The Rights Plan is not intended to interfere with any transaction approved by the Board of Directors. The Board of Directors is committed to acting in the best interests of all of the Company’s stockholders.

Scorpio Bulkers Inc., together with its auxiliaries, engages in the marine transportation of dry bulk commodities. Its fleet transports a range of major and minor bulk commodities, counting ores, coal, grains, and fertilizers along worldwide shipping routes. As of April 02, 2015, the company owned eight vessels compriseing of one Capesize, three Kamsarmax, and four Ultramax vessels; had time charters-in 13 dry bulk vessels comprised of one Handymax, one Ultramax, three Supramax, two Panamax, three Kamsarmax, and three Post-Panamax vessels; and contracted for 63 dry bulk vessels, which comprised of 25 Ultramax, 20 Kamsarmax, and 18 Capesize vessels from shipyards in Japan, South Korea, China, and Romania. Scorpio Bulkers Inc. was founded in 2013 and is based in Monaco.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.

 




Leave a Reply

Your email address will not be published. Required fields are marked *